Hatem A. Azim

11.0k citations

120 papers · 5.5k indexed · 1 hit paper · h-index 36

Impact in

Oncology top 0.5%
- Cancer Risks and Factors
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
Cancer Research top 1%
- Breast Cancer Treatment Studies

Papers in

Oncology 93
- Cancer Risks and Factors 49
- HER2/EGFR in Cancer Research 19
Cancer Research 35
- Breast Cancer Treatment Studies 29
- Cancer Genomics and Diagnostics 10

Co-authors: Fedro A. Peccatori Martine Piccart Nicholas Pavlidis Ann H. Partridge Evandro de Azambuja Hamdy A. Azim Christos Sotiriou Sherene Loi
Journals: Annals of Oncology (14 papers)Journal of Clinical Oncology (14 papers)The Breast (11 papers)Cancer Treatment Reviews (10 papers)European Journal of Cancer (5 papers)
Partner nations: Belgium Italy United States

In The Last Decade

Hatem A. Azim

116 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 2013 · 528 citations

Peers

Countries citing papers authored by Hatem A. Azim

Since Specialization

Citations

This map shows the geographic impact of Hatem A. Azim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatem A. Azim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatem A. Azim more than expected).

Fields of papers citing papers by Hatem A. Azim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatem A. Azim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatem A. Azim. The network helps show where Hatem A. Azim may publish in the future.

Co-authors

The 25 scholars most cited alongside Hatem A. Azim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hatem A. Azim Line = papers co-authored together Hatem A. Azim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LBA12 5-year follow-up results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial Annals of Oncology ·Hyeong Min Kim, Samuel M. Niman, Marco Ruggeri, Fedro A. Peccatori, Hatem A. Azim, E Pollitt, C. Saura Manich, Chikako Shimizu, NAE-EUNG LEE, 张文足, Erica T. Warner, Audrey Mailliez, Frédéric Amant, Henni Nurminen, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, R.D. Gelber, AH Partridge	2025	0
2	Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles Cells ·Elham Sajjadi, Konstantinos Venetis, Marianna Noale, Hatem A. Azim, Concetta Blundo, Giuseppina Bonizzi, Siti Halimah, Giovanna Scarfone, Stefano Ferrero, Stefania Maggi, Massimo Barberis, Paolo Veronesi, Viviana Galimberti, Giuseppe Viale, Nicola Fusco, Fedro A. Peccatori, Elena Guerini‐Rocco	2022	10
3	Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case–control study Breast Cancer Research and Treatment ·Wendy Munoz-Moñtano, Paula Cabrera‐Galeana, Cynthia De la Garza‐Ramos, Hatem A. Azim, O. N. Mokhova, LilHelpHere, Jaysa Amariz, Valeria Beatríz, Alberto Alvarado‐Miranda, Fernando Lara-Medina, Xiangfeng Huang, Enrique Bargalló‐Rocha, Óscar Arrieta, Cynthia Villarreal‐Garza	2021	9
4	8P Knowledge, practice and attitudes of physicians in low- and middle-income countries (LMIC) on fertility and pregnancy-related issues in young breast cancer patients Annals of Oncology ·Roel Brandt, Jong-Hwa Lee, Bhawna Sirohi, Noam Pondé, A S Girshovich, Mariana Brandão, Hatem A. Azim, Sebastião A. S. Júnior, P. Blanford, Lu Yao, 랭 바흐 트루옹, RAY KESTEVEN, YEXiang, Vanessa Mendonça Felizardo De, 杏里橋本, I Beck Commander, Bishal Gyawali, Dario Trapani, Marco Tagliamento, Matteo Lambertini	2020	1
5	Clinical utility of genomic signatures in young breast cancer patients: a systematic review npj Breast Cancer ·Cynthia Villarreal‐Garza, Ana S. Ferrigno, Cynthia De la Garza‐Ramos, Regina Barragán-Carrillo, Matteo Lambertini, Hatem A. Azim	2020	26
6	Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221 Clinical Cancer Research ·Anna V. Tinker, Holger W. Hirte, Diane Provencher, Marcus O. Butler, Chen Chang, Dongsheng Tu, Hatem A. Azim, 淳石川, 教頭法令実務研究会, Danielle Kupecek, Dušan Mihailović, Lesley Seymour	2019	70
7	Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial Journal of Clinical Oncology ·Amir Sonnenblick, Dominique Agbor‐Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Séverine Sarp, Antonio C. Wolff, Michael Andersson, Judith R. Kroep, Tanja Čufer, Sérgio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay N. Harris, Julie R. Gralow, Maccon Keane, Alvaro Moreno‐Aspitia, Martine Piccart, Evandro de Azambuja	2017	106
8	Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial JNCI Journal of the National Cancer Institute ·Isabelle Gingras, Eileen Holmes, Evandro de Azambuja, David H. Nguyen, Miguel Izquierdo, Jo Anne Zujewski, Moshe Inbar, Bjørn Naume, Gianluca Tomasello, Julie R. Gralow, Antonio C. Wolff, Lyndsay N. Harris, Michael Gnant, Alvaro Moreno‐Aspitia, Martine Piccart, Hatem A. Azim	2016	19
9	Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies Cancer Treatment Reviews ·Matteo Lambertini, Luigi Santoro, Lucia Del Mastro, Bastien Nguyen, Luca Livraghi, Donatella Ugolini, Fedro A. Peccatori, Hatem A. Azim	2016	157
10	Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial JNCI Journal of the National Cancer Institute ·Amir Sonnenblick, Evandro de Azambuja, Dominique Agbor‐Tarh, Ian Bradbury, Christine Campbell, Yingjie Huang, Amylou C. Dueck, Kathleen I. Pritchard, Antonio C. Wolff, Christian Jackisch, István Láng, Michael Untch, Ian Smith, Frances Boyle, Binghe Xu, Henry Gómez, Edith A. Perez, Martine Piccart, Hatem A. Azim	2016	22
11	Aromatase inhibitors in male breast cancer: a pooled analysis Breast Cancer Research and Treatment ·Flora Zagouri, Theodoros Ν. Sergentanis, Hatem A. Azim, Dimosthenis Chrysikos, Meletios Α. Dimopoulos, Θεοδώρα Ψαλτοπούλου	2015	23
12	Genomic aberrations in young and elderly breast cancer patients BMC Medicine ·Hatem A. Azim, Bastien Nguyen, Sylvain Brohée, Gabriele Zoppoli, Christos Sotiriou	2015	79
13	Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis PLoS ONE ·Hatem A. Azim, Sandeep K. Singhal, Michail Ignatiadis, Christine Desmedt, Debora Fumagalli, Isabelle Veys, Denis Larsimont, Martine Piccart, Stefan Michiels, Christos Sotiriou	2013	3
14	Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial Journal of Clinical Oncology ·Hatem A. Azim, Dominique Agbor‐Tarh, Ian Bradbury, Phuong Dinh, José Baselga, Serena Di Cosimo, James Greger, Ian Smith, Christian Jackisch, Sung‐Bae Kim, Bahriye Aktas, Chiun‐Sheng Huang, Peter Vuylsteke, Ruey Kuen Hsieh, Lydia Dreosti, Holger Eidtmann, Martine Piccart, Evandro de Azambuja	2013	45
15	Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling Clinical Cancer Research ·Hatem A. Azim, Stefan Michiels, Philippe L. Bédard, Sandeep K. Singhal, Carmen Criscitiello, Michail Ignatiadis, Benjamin Haibe‐Kains, Martine Piccart, Christos Sotiriou, Sherene Loi	2012	278
16	Systemic Treatment of Brain Metastases in HER2-Positive Breast Cancer: Current Status and Future Directions Future Oncology ·Hamdy A. Azim, Hatem A. Azim	2012	14
17	Breastfeeding in breast cancer survivors: Pattern, behaviour and effect on breast cancer outcome The Breast ·Hatem A. Azim, Escolar Esteban, Sarah Liptrott, Brasil. Ministério da Saúde. Secretaria Assistência à Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS., V. Dell’Acqua, Francesca Torti, 최병옥, Viviana Galimberti, Fedro A. Peccatori	2010	38
18	Rituximab in Hodgkin lymphoma: Is the target always a hit? Cancer Treatment Reviews ·Kamal S. Saini, Hatem A. Azim, Emilia Cocorocchio, Anna Vanazzi, Monika Lamba Saini, Paola Rafaniello Raviele, Giancarlo Pruneri, Fedro A. Peccatori	2010	30
19	Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: A systematic overview Lung Cancer ·Hatem A. Azim, Inas Elattar, Fausto R. Loberiza, Hamdy A. Azim, Tony Mok, Apar Kishor Ganti	2008	28
20	Imatinib in the Treatment of Follicular Dendritic Sarcoma: A Case Report and Review of Literature Oncology Research and Treatment ·Hamdy A. Azim, F. S. Macomber, Hatem A. Azim	2007	17

About Hatem A. Azim

Hatem A. Azim is a scholar working on Oncology, Cancer Research, Genetics, Public Health, Environmental and Occupational Health and Dermatology, having authored 120 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Risks and Factors (49 papers), Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (19 papers), BRCA gene mutations in cancer (17 papers), Multiple and Secondary Primary Cancers (12 papers), Reproductive Biology and Fertility (11 papers), Cancer Genomics and Diagnostics (10 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.6k citations), Reproductive Medicine (703 citations), Public Health, Environmental and Occupational Health (1.1k citations) and Pediatrics, Perinatology and Child Health (648 citations). Hatem A. Azim has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Fedro A. Peccatori, Martine Piccart, Nicholas Pavlidis, Ann H. Partridge, Evandro de Azambuja, Hamdy A. Azim, Christos Sotiriou, Sherene Loi, Amir Sonnenblick and Matteo Lambertini. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Breast, Cancer Treatment Reviews and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact